Mike Cavanaugh
Investor Relations
Replay available
NANO-X IMAGING LTD (NASDAQ: NNOX) Q2 2025 earnings conference call, held 2025-08-12. Replay captured from the company's public earnings webcast.

Investor Relations
Chief Executive Officer and Acting Chairman
Chief Financial Officer
Analyst, Cantor Fitzgerald
Analyst, AGP
Analyst, Ladenburg (Latinburg)
Watch the replay and follow the connected company analysis, news, and investor updates for Nano-x Imaging Ltd.
WEBVTT 00:00:00.031 -- 00:00:04.498 Good day, and thank you for standing by. Welcome to the NANOX Imaging Second Quarter 00:00:04.498 -- 00:00:09.806 2025 Earnings Call. At this time, all participants are in a listen-only mode. 00:00:09.806 -- 00:00:13.051 After the speaker's presentation, we'll open up for questions. 00:00:13.051 -- 00:00:17.678 To ask a question during the session, you will need to press star 1-1 on your telephone. 00:00:17.678 -- 00:00:20.983 You will then hear an automated message advising your hand is raised. 00:00:20.983 -- 00:00:23.226 To withdraw your question, please press star 1-1 again. 00:00:23.226 -- 00:00:26.972 Please be advised that today's conference is being recorded. 00:00:26.972 -- 00:00:31.610 I would now like to hand it over to your first speaker, Mike Cavanaugh, Investor Relations. 00:00:31.610 -- 00:00:34.050 Please go ahead. 00:00:34.893 -- 00:00:37.355 Good morning and thank you for joining us today. 00:00:37.355 -- 00:00:41.739 Earlier today, Nanox Imaging Limited released financial results for the quarter ended 00:00:41.739 -- 00:00:45.022 June 30, 2025. The 00:00:45.022 -- 00:00:50.387 release is currently available on the investor section of the company's website. 00:00:50.387 -- 00:00:55.131 With me today are Eris Meltzer, Chief Executive Officer and Acting Chairman, and Ron 00:00:55.131 -- 00:00:58.199 Daniel, Chief Financial Officer. 00:00:58.199 -- 00:01:02.004 Before we get started, I would like to remind everyone that management will be making 00:01:02.004 -- 00:01:06.230 statements during this call that include forward-looking statements regarding the company's 00:01:06.230 -- 00:01:12.238 financial results, research and development, manufacturing and commercialization activities, 00:01:12.238 -- 00:01:16.885 regu...